Article Details
Retrieved on: 2021-03-25 12:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Moreover, engineered monoclonal antibodies can target mTOR protein in order to restrict new blood vessel formation or hamper growth of tumor cells.
Article found on: www.pharmiweb.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here